JPS5416491A - Substituted 1*2*44triazines having pharmacological action - Google Patents

Substituted 1*2*44triazines having pharmacological action

Info

Publication number
JPS5416491A
JPS5416491A JP5814578A JP5814578A JPS5416491A JP S5416491 A JPS5416491 A JP S5416491A JP 5814578 A JP5814578 A JP 5814578A JP 5814578 A JP5814578 A JP 5814578A JP S5416491 A JPS5416491 A JP S5416491A
Authority
JP
Japan
Prior art keywords
substituted
pharmacological action
pharmacological
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5814578A
Other languages
English (en)
Japanese (ja)
Inventor
Maukeru Garo Jieemusu
Pooru Heiruman Uiriamu
Jiyon Ueinaa Robaato
Yuujin Mozaa Robaato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diamond Shamrock Corp
Original Assignee
Diamond Shamrock Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/897,803 external-priority patent/US4157392A/en
Application filed by Diamond Shamrock Corp filed Critical Diamond Shamrock Corp
Publication of JPS5416491A publication Critical patent/JPS5416491A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP5814578A 1977-05-17 1978-05-16 Substituted 1*2*44triazines having pharmacological action Pending JPS5416491A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79767677A 1977-05-17 1977-05-17
US05/897,803 US4157392A (en) 1977-05-17 1978-04-19 Pharmacologically active substituted 1,2,4-triazines

Publications (1)

Publication Number Publication Date
JPS5416491A true JPS5416491A (en) 1979-02-07

Family

ID=27121911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5814578A Pending JPS5416491A (en) 1977-05-17 1978-05-16 Substituted 1*2*44triazines having pharmacological action

Country Status (8)

Country Link
JP (1) JPS5416491A (fr)
CA (1) CA1128507A (fr)
CH (1) CH633541A5 (fr)
DE (1) DE2821381A1 (fr)
FR (1) FR2391202A1 (fr)
GB (3) GB1604083A (fr)
IL (1) IL54728A (fr)
IT (1) IT1105463B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014515776A (ja) * 2011-04-14 2014-07-03 コンパニー ゼネラール デ エタブリッスマン ミシュラン １，２，４‐トリアジン誘導体を含むゴム組成物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485531A1 (fr) * 1980-06-25 1981-12-31 Fabre Sa Pierre Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
US4513135A (en) * 1982-03-05 1985-04-23 Eli Lilly And Company Diaryl-pyrazine derivatives affecting GABA binding
US4581356A (en) * 1983-03-22 1986-04-08 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
TWI316055B (fr) * 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
ES2579949T3 (es) 2010-02-05 2016-08-17 Heptares Therapeutics Limited Derivados de 1,2,4-triazin-4-amina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2343478A1 (fr) * 1976-03-10 1977-10-07 Lilly Co Eli Nouvelles 5,6-diaryl-1,2,4-triazines et leur utilisation comme agents anti-inflammatoires locaux
FR2368278A1 (fr) * 1976-10-25 1978-05-19 Fabre Sa Pierre Nouveaux medicaments antalgiques contenant des triazines 1-2-4

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014515776A (ja) * 2011-04-14 2014-07-03 コンパニー ゼネラール デ エタブリッスマン ミシュラン １，２，４‐トリアジン誘導体を含むゴム組成物

Also Published As

Publication number Publication date
IT7849404A0 (it) 1978-05-16
FR2391202A1 (fr) 1978-12-15
IT1105463B (it) 1985-11-04
GB1604084A (en) 1981-12-02
FR2391202B1 (fr) 1982-04-02
IL54728A0 (en) 1978-07-31
IL54728A (en) 1983-06-15
GB1604085A (en) 1981-12-02
DE2821381A1 (de) 1978-11-30
CH633541A5 (en) 1982-12-15
CA1128507A (fr) 1982-07-27
GB1604083A (en) 1981-12-02

Similar Documents

Publication Publication Date Title
NZ187453A (en) Benzsubstituted-1-substitutedpiperid-1'-ylphthalazines
GR63684B (en) Substituted 3-aminopyrazolia
JPS53121009A (en) Ceramicssmetal structures
JPS53144592A (en) 122alkyll1*4*7*100tetrazacyclotridecane
JPS5484554A (en) 11nn4*66diioo*aminoglycocyl**1*33diamino sicritol derivatives
JPS53141269A (en) Substituted isooxazolylbenzoates
GB1557552A (en) 1 oxadethiacepham compounds
JPS5390280A (en) Substituted 11alkylthiophenyll 2*3*4*55tetrahydroo1hh33benzazepine compound
MTP837B (en) Derivatives 2 finino-imidazolidire
JPS5416491A (en) Substituted 1*2*44triazines having pharmacological action
JPS53130685A (en) 11substitutedd33amimoo6*77dialkoxyy1*2*44 benzothiadiazinee11oxides
JPS54163581A (en) 2*22di substitutedd77substituteddchromann44 onee55carboxyaldehyde
JPS5398981A (en) Semiisynthesis 4**aminoooreandomycine derivative
JPS5412313A (en) Glycerylltrii3*5*55trimethylhexanoate
JPS5419978A (en) 1*2*44oxadiazol derivative
JPS5424887A (en) Semiisynthetic 4***ureidoooleandomycin derivative
AU3967878A (en) Substituted n-phenyl-succinimides
JPS5476586A (en) 2*44diaminoo55benzylpyrimidines
JPS5390281A (en) 11phenyll2*3*4*55tetrahydroo1hh33 benzazepines
GB2002367B (en) Substituted 2-cyclopropyl-chromones
JPS5444692A (en) 10*111dihydroo111oxobenzo*b*f*thiepine compound
JPS5466657A (en) 55isopropyll11oxaspiro*2*4*heptoo44ene
NZ187675A (en) 1-imidazolidin-2'-ylideneaminoindolines
JPS53112827A (en) Novel 11phenyll22aminoo1*33 propanediole*nnalkyl derivative
GB2001970B (en) Substituted 11-aminoundecanols